Polynovo Ltd has released a press release.
USA FDA approves Pivotal Trial IDE
Filed with ASX ·
Watch Polynovo's latest callPolynovo (ASX:PNV) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Polynovo (ASX:PNV) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Earlier from Polynovo
- Taiwan FDA Approval for PolyNovo
- Appointment of distributor for Finland
- FY20 Results Presentation
- Appendix 4E and FY20 Annual Report
- BARDA funding for Pivotal Trial
Later from Polynovo
- Chairman, Managing Director & SVP of Sales US - AGM address
- PolyNovo enters Belgium, Netherlands, Luxemburg & Sweden
- Trading Update - H1 FY21
- Response to ASX Query
- PolyNovo enters Poland - Distributor Appointment
Follow Polynovo into a list and get an email when it puts out news.
Follow Polynovo